Omega Healthcare Investors Inc financial data

Symbol
OHI on NYSE
Location
303 International Circle,, Suite 200, Hunt Valley, MD
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Oct 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 107 % -22.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 296M shares +9.48%
Common Stock, Shares, Outstanding 296M shares +10.2%
Entity Public Float 8.7B USD +17.6%
Common Stock, Value, Issued 29.6M USD +10.2%
Weighted Average Number of Shares Outstanding, Basic 296M shares +12.6%
Weighted Average Number of Shares Outstanding, Diluted 308M shares +11.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.15B USD +13.7%
General and Administrative Expense 102M USD +21.8%
Income Tax Expense (Benefit) 15.6M USD +29.6%
Net Income (Loss) Attributable to Parent 180M USD +60.8%
Earnings Per Share, Basic 1 USD/shares +29.3%
Earnings Per Share, Diluted 1 USD/shares +30.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 737M USD +115%
Operating Lease, Right-of-Use Asset 28.3M USD -6.22%
Goodwill 645M USD +0.01%
Assets 10.6B USD +10.7%
Liabilities 5.35B USD +3.49%
Accumulated Other Comprehensive Income (Loss), Net of Tax 77M USD +22.7%
Retained Earnings (Accumulated Deficit) 4.51B USD +13.6%
Stockholders' Equity Attributable to Parent 5.04B USD +19.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 5.24B USD +19.2%
Liabilities and Equity 10.6B USD +10.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 182M USD +20.1%
Net Cash Provided by (Used in) Financing Activities -348M USD -86.9%
Net Cash Provided by (Used in) Investing Activities 19.3M USD
Common Stock, Shares Authorized 700M shares +100%
Common Stock, Shares, Issued 296M shares +10.2%
Common Stock, Par or Stated Value Per Share 0.1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -145M USD -77.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 775M USD +115%
Interest Paid, Excluding Capitalized Interest, Operating Activities 63.1M USD +7.94%
Deferred Tax Assets, Valuation Allowance 1.93M USD -4.89%
Operating Lease, Liability 30.3M USD -4.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 553M USD +44.5%
Deferred Tax Assets, Operating Loss Carryforwards 2.05M USD -1.49%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) 15.6M USD +29.5%
Preferred Stock, Shares Authorized 20M shares 0%
Additional Paid in Capital 8.52B USD +13.9%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 321M USD +6.43%
Share-based Payment Arrangement, Expense 43.5M USD +19.9%
Preferred Stock, Par or Stated Value Per Share 1 USD/shares 0%